Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / STML - Stemline Therapeutics: Still A Believer


STML - Stemline Therapeutics: Still A Believer

A cynic is a man who, when he smells flowers, looks around for a coffin.”? H.L. Mencken

Today, we revisit a 'Tier 3' concern that has seen a fall in its share price despite a spate of good news. This gives investors a nice entry point to establish a new position or add exposure to this undervalued gem.

Company Overview

Stemline Therapeutics (STML) is a New York-based biotech concern. The company is focused on developing novel oncology therapeutics. The company has one approved product called ELZONRIS and its other clinical

Read more ...

Stock Information

Company Name: Stemline Therapeutics Inc.
Stock Symbol: STML
Market: NASDAQ
Website: stemline.com

Menu

STML STML Quote STML Short STML News STML Articles STML Message Board
Get STML Alerts

News, Short Squeeze, Breakout and More Instantly...